Literature DB >> 1309997

Glycoprotein-specific immune response in canine herpesvirus infection.

X Xuan1, T Horimoto, J A Limcumpao, Y Tohya, E Takahashi, T Mikami.   

Abstract

Sera from dogs which were infected with canine herpesvirus (CHV) were analyzed for their serological reactivities against virus-specific glycoproteins (gps). By sequential immunoblot analysis using sera from experimentally infected dogs, it was found that the antibody response to gp 145/112 appeared first followed by responses to gp47 and gp80. In addition, all sera from naturally infected dogs which showed neutralizing activity to CHV reacted with gp 145/112, whereas 77% and 70% reacted with gp47 and gp80, respectively. Furthermore, some of the sera also cross-neutralized feline herpesvirus type 1 (FHV-1) and reacted with gp 143/108 of FHV-1, indicating that gp 145/112 of CHV induced cross-neutralizing antibody response to FHV-1.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1309997     DOI： 10.1007/bf01317197

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  23 in total

1.  Neutralizing determinants of canine herpesvirus as defined by monoclonal antibodies.

Authors:  X Xuan; T Horimoto; J A Limcumpao; A Takumi; Y Tohya; E Takahashi; T Mikami
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

2.  Studies on cytopathogenic viruses from cats with respiratory infections. III. Isolation and certain properties of feline herpesviruses.

Authors:  M Mochizuki; S Konishi; M Ogata
Journal:  Nihon Juigaku Zasshi       Date:  1977-02

3.  Demonstration of canine herpesvirus-specific hemagglutination.

Authors:  K Nemoto; T Horimoto; X N Xuan; K Kusanagi; A Takumi; Y Tohya; M Azetaka; E Takahashi; T Mikami
Journal:  Nihon Juigaku Zasshi       Date:  1990-04

4.  Enhancement of neutralizing activity of anti-feline herpesvirus type 1 sera by complement supplementation.

Authors:  T Horimoto; J A Limcumpao; Y Tohya; E Takahashi; T Mikami
Journal:  Nihon Juigaku Zasshi       Date:  1989-10

5.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

6.  Herpesvirus canis: aspects of pathogenesis and immune response.

Authors:  L E Carmichael
Journal:  J Am Vet Med Assoc       Date:  1970-06-15       Impact factor: 1.936

7.  Canine herpesvirus 47 kD and mutated 41 kD glycoproteins are responsible for hemagglutination.

Authors:  X N Xuan; T Horimoto; J A Limcumpao; K Nemoto; Y Tohya; M Azetaka; E Takahashi; T Mikami
Journal:  Nihon Juigaku Zasshi       Date:  1990-10

8.  Serodiagnosis of canine herpesvirus infection--development of an enzyme-linked immunosorbent assay and its comparison with two improved methods of serum neutralization test.

Authors:  A Takumi; K Kusanagi; K Tuchiya; X N Xuan; M Azetaka; E Takahashi
Journal:  Nihon Juigaku Zasshi       Date:  1990-04

9.  The immunological relationship between canine herpesvirus and four other herpesviruses.

Authors:  A Manning; A Buchan; G R Skinner; J Durham; H Thompson
Journal:  J Gen Virol       Date:  1988-07       Impact factor: 3.891

10.  Homologous and heterologous antibody responses of mice immunized with purified feline herpesvirus type 1 and canine herpesvirus glycoproteins.

Authors:  J A Limcumpao; T Horimoto; X N Xuan; Y Tohya; M Azetaka; E Takahashi; T Mikami
Journal:  J Vet Med Sci       Date:  1991-06       Impact factor: 1.267
View more
  2 in total

1.  Nucleotide sequence of glycoprotein genes B, C, D, G, H and I, the thymidine kinase and protein kinase genes and gene homologue UL24 of an Australian isolate of canine herpesvirus.

Authors:  Gerhard Herbert Reubel; Jenny Pekin; Kyleen Webb-Wagg; Christopher Miles Hardy
Journal:  Virus Genes       Date:  2002-10       Impact factor: 2.332

2.  Non-suppurative meningoencephalitis of unknown origin in cats and dogs: an immunohistochemical study.

Authors:  S Schwab; C Herden; F Seeliger; N Papaioannou; D Psalla; Z Polizopulou; W Baumgärtner
Journal:  J Comp Pathol       Date:  2007-02-01       Impact factor: 1.311
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.